Image

Voice Biomarkers to Predict Excessive Daytime Sleepiness

Recruiting
18 - 50 years of age
Both
Phase N/A

Powered by AI

Overview

This study aims at measuring the impact of a night of sleep deprivation over the vocal characteristics of healthy subjects.To do so, the subjects takes a Multiple Sleep Latency Test (MSLT) the day after a night of total sleep deprivation (or a supervised normal night for the control subjects). Before each iteration of the MSLT, the subjects are recorded during the reading of a text and fill three medical questionnaires : Karolinska Sleepiness Scale (KSS), Visual Analogue Scale for Fatigue (VAS-F) and Visual Analogue Scale for Anxiety (VAS-A), allowing to link variations of vocal markers to the variations of these measures.

Description

Excessive Daytime Sleepiness (EDS) is a frequent symptom that concerns between 5% and 8% of the population. The individual consequence of EDS is a diminution of the life quality. Furthermore, EDS is a cause of high socio-medical costs though the accidental risks that it induces at work and on the road (Ohayon, Reynolds et al. 2013). Indeed, it is a severe symptom due to the consequences that it is the cause of. Furthermore, EDS is associated to 5 to 20% of road accidents depending on the type of road network. As a consequence, to elaborate a sleepiness detection through voice in real time system is a major challenge for public health-care and medicine. Moreover, it offers benefits from a socio-medical aspect, as detecting sleepiness through voice doesn't require neither consumables furniture nor specialized staff to be set up.

To highlight the effect of sleepiness over voice, investigators designed this experiment around a night of total sleep deprivation. To measure objective sleepiness of subjects, they takes a MSLT test the day after a night of total sleep deprivation (or a supervised night for control). The complementary measures (KSS, VAS-A, VAS-F and Psychomotor Vigilance Task (PVT)) will allow to study the exact origin of the variations of the vocal markers induced by the sleep deprivation.

Eligibility

Inclusion Criteria:

  • Male ou female volunteers, who are between 18 and 50 years old,
  • With a BMI (Body Mass Index) between 18.5 and 25 kg/m2 for volunteers who are between 18 and 34 years old, or a BMI between 18.5 and 27 kg/m2 for volunteers who are between 35 and 50 years old ,
  • Not having subjective EDS (Excessive Daytime Sleepiness) : total score at ESS (Epworth Sleepiness Scale) lower or equal to 11,
  • Not having insomnia complaints (ISI total score lower than 8),
  • Having a SCL90R (Symptom Check List- 90 items Revised) score lower than 60 (only for Anxiety and Depression categories' items of the checklist),
  • Regular bedtime between 22H00 and 0H00, regular get up time between 6H00 and 8H00,
  • Daily TST (Total Sleep Time) between 7 and 9 hours,
  • With no strong suspicion of OSAS (Obstructive Sleep Apnea Syndrome) as assessed by STOP-BANG questionnaire,
  • With no suspicion of RLS (Restless Legs Syndrome) as assessed by RLS screening questionnaire,
  • With sufficient reading abilities for the reading task as assessed by ECLA16+ ("Evaluation des Compétences de Lecture chez l'Adulte de plus de 16 ans" :
        higher ou equal performances than 25th percentile for performances assessed in total
        population for the following tasks : " lecture de " l'Alouette " " (Number of correctly
        read words / minute ≥ 121, number of errors ≤ 10), isolated words reading (regular words :
        score ≥ 18, time ≤ 17 sec ; irregular words : score ≥ 16, time ≤ 16 sec, pseudo-words :
        score ≥ 17, time ≤ 26 sec), repetition of non-words (score ≥ 19), and symbol crossing task
        (number of crossed symbols ≥ 22),
          -  With a SE (Sleep Efficiency) higher or equal to 85% as assessed by the 7
             nights-actigraphy made before inclusion,
          -  With an AHI (Apnea/Hypopnea Index) lower or equal to 10 apnea or hypopnea/hour of
             sleep as assessed by the ventilatory polygraphy,
          -  With a PLMI (Periodic Limb Movement Index) lower or equal to 15 sequences of PLM/hour
             of sleep as assessed by the ventilatory polygraphy,
          -  Being an affiliated member of the Social Security system,
          -  Being able to understand the study,
          -  Being available to come at the four visits necessary for the study,
          -  Having given written informed consent to participate to the study.
        Exclusion Criteria:
          -  Having a life-threatening disease,
          -  Any evolutive cardiovascular pathology - under treatment or not,
          -  Any evolutive neurologic pathology - under treatment or not (brain tumour, epilepsy,
             headache, stroke, sclerosis, myoclonia, chorea, neuropathy, muscular dystrophies,
             myotonic dystrophy),
          -  Psychiatric disorders - under treatment or not (characterised depressive episode,
             bipolar disorders, psychotic disorders, neurodevelopmental diseases),
          -  Untreated endocrine disorders (diabetes, hyperthyroidism),
          -  Dependency to a substance,
          -  otorhinolaryngological disorder that could induce vocal parameters modification,
          -  Fluence disorders (cluttering, stuttering), language disorders (dyslexia) or visual
             troubles that could impact reading abilities,
          -  Participant under psychotropic treatment (antidepressants, antihistamine, etc…), or
             under treatment that could interfere with sleep or wakefulness level,
          -  Participant under treatment that could impact the normal muscular function
             (myorelaxant, neuromuscular blocking agents injections in maxillofacial area, etc…),
          -  Dental care during the follow-up of the study,
          -  Shift-worker or night-worker,
          -  Excessive consumption of alcohol (>2 glasses per day) during the 6 last months,
          -  Excessive consumption of coffee, tea, or any drink containing caffeine (like cola) (>
             5 cups/day),
          -  Excessive tobacco smoking (>5 cigarets/day),
          -  Non-native French speaker,
          -  Participant with a thick accent that could induce significantly vocal parameters
             modification (at the discretion of the investigator),
          -  Deprived of liberty by a legal or administrative procedure,
          -  Under tutorship or guardianship,
          -  Pregnant or breastfeeding woman.

Study details

Sleep Deprivation

NCT04942574

University Hospital, Bordeaux

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.